Medical isotope developer IsoRay announced that University Hospital in Rostock, Germany, became the first European hospital to use its GliaSite radiation therapy system, a liquid I-125 balloon catheter.
The GliaSite system is used to treat patients with glioblastoma and metastatic brain cancer. It places a specified high dose of a liquid radiation source in areas that are most likely to contain cancer after a tumor is surgically excised from the brain.
The GliaSite radiation therapy has CE Mark approval.